Related references
Note: Only part of the references are listed.The PML hub: An emerging actor of leukemia therapies
Domitille Rerolle et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2023)
Oncohistones: a roadmap to stalled development
Shriya Deshmukh et al.
FEBS JOURNAL (2022)
H3-K27M-mutant nucleosomes interact with MLL1 to shape the glioma epigenetic landscape
Noa Furth et al.
CELL REPORTS (2022)
Histone H3.3 K27M and K36M mutations de-repress transposable elements through perturbation of chromatin marks
Amel Chaouch et al.
MOLECULAR CELL (2021)
Twelve years of SAMtools and BCFtools
Petr Danecek et al.
GIGASCIENCE (2021)
Mutations inhibiting KDM4B drive ALT activation in ATRX-mutated glioblastomas
M. Udugama et al.
NATURE COMMUNICATIONS (2021)
Simultaneous disruption of PRC2 and enhancer function underlies histone H3.3-K27M oncogenic activity in human hindbrain neural stem cells
Gerard L. Brien et al.
NATURE GENETICS (2021)
The Galaxy platform for accessible, reproducible and collaborative biomedical analyses: 2020 update
Vahid Jalili et al.
NUCLEIC ACIDS RESEARCH (2020)
PML nuclear bodies and chromatin dynamics: catch me if you can!
Armelle Corpet et al.
NUCLEIC ACIDS RESEARCH (2020)
Base-resolution methylomes of gliomas bearing histone H3.3 mutations reveal a G34 mutant-specific signature shared with bone tumors
Yuhei Sangatsuda et al.
SCIENTIFIC REPORTS (2020)
Histone deposition pathways determine the chromatin landscapes of H3.1 and H3.3 K27M oncohistones
Jay F. Sarthy et al.
ELIFE (2020)
SAMMY-seq reveals early alteration of heterochromatin and deregulation of bivalent genes in Hutchinson-Gilford Progeria Syndrome
Endre Sebestyen et al.
NATURE COMMUNICATIONS (2020)
PML modulates H3.3 targeting to telomeric and centromeric repeats in mouse fibroblasts
Jane Spirkoski et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2019)
Pervasive H3K27 Acetylation Leads to ERV Expression and a Therapeutic Vulnerability in H3K27M Gliomas
Brian Krug et al.
CANCER CELL (2019)
Vulnerabilities in mIDH2 AML confer sensitivity to APL-like targeted combination therapy
Vera Mugoni et al.
CELL RESEARCH (2019)
Stalled developmental programs at the root of pediatric brain tumors
Selin Jessa et al.
NATURE GENETICS (2019)
H3.3 K27M depletion increases differentiation and extends latency of diffuse intrinsic pontine glioma growth in vivo
Andre B. Silveira et al.
ACTA NEUROPATHOLOGICA (2019)
H3K27M induces defective chromatin spread of PRC2-mediated repressive H3K27me2/me3 and is essential for glioma tumorigenesis
Ashot S. Harutyunyan et al.
NATURE COMMUNICATIONS (2019)
PML nuclear bodies: from architecture to function
Valerie Lallemand-Breitenbach et al.
CURRENT OPINION IN CELL BIOLOGY (2018)
Histone H3.3 G34 Mutations Alter Histone H3K36 and H3K27 Methylation In Cis
Leilei Shi et al.
JOURNAL OF MOLECULAR BIOLOGY (2018)
Ribosomal DNA copy loss and repeat instability in ATRX-mutated cancers
Maheshi Udugama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2018)
Inhibition of a K9/K36 demethylase by an H3.3 point mutation found in paediatric glioblastoma
Hsiao P. J. Voon et al.
NATURE COMMUNICATIONS (2018)
Multiple modes of PRC2 inhibition elicit global chromatin alterations in H3K27M pediatric glioma
James M. Stafford et al.
SCIENCE ADVANCES (2018)
PML protein organizes heterochromatin domains where it regulates histone H3.3 deposition by ATRX/DAXX
Erwan Delbarre et al.
GENOME RESEARCH (2017)
Therapeutic targeting of polycomb and BET bromodomain proteins in diffuse intrinsic pontine gliomas
Andrea Piunti et al.
NATURE MEDICINE (2017)
Acute Promyelocytic Leukemia: A Paradigm for Oncoprotein-Targeted Cure
Hugues de The et al.
CANCER CELL (2017)
Integrated Molecular Meta-Analysis of 1,000 Pediatric High-Grade and Diffuse Intrinsic Pontine Glioma
Alan Mackay et al.
CANCER CELL (2017)
Histone 3.3 hotspot mutations in conventional osteosarcomas: a comprehensive clinical and molecular characterization of six H3F3A mutated cases
Christian Koelsche et al.
CLINICAL SARCOMA RESEARCH (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
deepTools2: a next generation web server for deep-sequencing data analysis
Fidel Ramirez et al.
NUCLEIC ACIDS RESEARCH (2016)
New players in heterochromatin silencing: histone variant H3.3 and the ATRX/DAXX chaperone
Hsiao P. J. Voon et al.
NUCLEIC ACIDS RESEARCH (2016)
Atrx promotes heterochromatin formation at retrotransposons
Dennis Sadic et al.
EMBO REPORTS (2015)
Histone H3.3 is required for endogenous retroviral element silencing in embryonic stem cells
Simon J. Elsasser et al.
NATURE (2015)
Functionally defined therapeutic targets in diffuse intrinsic pontine glioma (vol 21, pg 555, 2015)
Catherine S. Grasso et al.
NATURE MEDICINE (2015)
ATRX Plays a Key Role in Maintaining Silencing at Interstitial Heterochromatic Loci and Imprinted Genes
Hsiao P. J. Voon et al.
CELL REPORTS (2015)
An Inducible Lentiviral Guide RNA Platform Enables the Identification of Tumor-Essential Genes and Tumor-Promoting Mutations In Vivo
Brandon J. Aubrey et al.
CELL REPORTS (2015)
Contribution of the Two Genes Encoding Histone Variant H3.3 to Viability and Fertility in Mice
Michelle C. W. Tang et al.
PLOS GENETICS (2015)
Dynamics of histone H3.3 deposition in proliferating and senescent cells reveals a DAXX-dependent targeting to PML-NBs important for pericentromeric heterochromatin organization
Armelle Corpet et al.
CELL CYCLE (2014)
The PML-associated protein DEK regulates the balance of H3.3 loading on chromatin and is important for telomere integrity
Kristina Ivanauskiene et al.
GENOME RESEARCH (2014)
The genomic landscape of diffuse intrinsic pontine glioma and pediatric non-brainstem high-grade glioma
Gang Wu et al.
NATURE GENETICS (2014)
Recurrent activating ACVR1 mutations in diffuse intrinsic pontine glioma
Kathryn R. Taylor et al.
NATURE GENETICS (2014)
Recurrent somatic mutations in ACVR1 in pediatric midline high-grade astrocytoma
Adam M. Fontebasso et al.
NATURE GENETICS (2014)
Reduced H3K27me3 and DNA Hypomethylation Are Major Drivers of Gene Expression in K27M Mutant Pediatric High-Grade Gliomas
Sebastian Bender et al.
CANCER CELL (2013)
Identification of Long-Lived Proteins Reveals Exceptional Stability of Essential Cellular Structures
Brandon H. Toyama et al.
CELL (2013)
Histone variants in pluripotency and disease
Peter J. Skene et al.
DEVELOPMENT (2013)
Conditional allelic replacement applied to genes encoding the histone variant H3.3 in the mouse
Michelle C. W. Tang et al.
GENESIS (2013)
DAXX-dependent supply of soluble (H3.3-H4) dimers to PML bodies pending deposition into chromatin
Erwan Delbarre et al.
GENOME RESEARCH (2013)
Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone
Sam Behjati et al.
NATURE GENETICS (2013)
PML bodies provide an important platform for the maintenance of telomeric chromatin integrity in embryonic stem cells
Fiona T. M. Chang et al.
NUCLEIC ACIDS RESEARCH (2013)
Inhibition of PRC2 Activity by a Gain-of-Function H3 Mutation Found in Pediatric Glioblastoma
Peter W. Lewis et al.
SCIENCE (2013)
Oncogenic Isocitrate Dehydrogenase Mutations: Mechanisms, Models, and Clinical Opportunities
Rob A. Cairns et al.
CANCER DISCOVERY (2013)
Enhancer identification in mouse embryonic stem cells using integrative modeling of chromatin and genomic features
Chih-yu Chen et al.
BMC GENOMICS (2012)
Chd2 interacts with H3.3 to determine myogenic cell fate
Akihito Harada et al.
EMBO JOURNAL (2012)
IDH mutations in acute myeloid leukemia
Dinesh Rakheja et al.
HUMAN PATHOLOGY (2012)
Transformation by the (R)-enantiomer of 2-hydroxyglutarate linked to EGLN activation
Peppi Koivunen et al.
NATURE (2012)
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Jeremy Schwartzentruber et al.
NATURE (2012)
Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas
Gang Wu et al.
NATURE GENETICS (2012)
rapidSTORM: accurate, fast open-source software for localization microscopy
Steve Wolter et al.
NATURE METHODS (2012)
Fast gapped-read alignment with Bowtie 2
Ben Langmead et al.
NATURE METHODS (2012)
The human histone H3 complement anno 2011
Thomas H. A. Ederveen et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2011)
Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent Dioxygenases
Wei Xu et al.
CANCER CELL (2011)
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Rasheduzzaman Chowdhury et al.
EMBO REPORTS (2011)
Dual Functions of Histone-Lysine N-Methyltransferase Setdb1 Protein at Promyelocytic Leukemia-Nuclear Body (PML-NB) MAINTAINING PML-NB STRUCTURE AND REGULATING THE EXPRESSION OF ITS ASSOCIATED GENES
Sunwha Cho et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
Ardeshir Ghavamzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
HP1-Mediated Formation of Alternative Lengthening of Telomeres-Associated PML Bodies Requires HIRA but Not ASF1a
Wei-Qin Jiang et al.
PLOS ONE (2011)
BEDTools: a flexible suite of utilities for comparing genomic features
Aaron R. Quinlan et al.
BIOINFORMATICS (2010)
PML/RARA Oxidation and Arsenic Binding Initiate the Antileukemia Response of As2O3
Marion Jeanne et al.
CANCER CELL (2010)
Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
Vikram Mathews et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate (vol 462, pg 739, 2010)
Lenny Dang et al.
NATURE (2010)
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres
Peter W. Lewis et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Estimating enrichment of repetitive elements from high-throughput sequence data
Daniel S. Day et al.
GENOME BIOLOGY (2010)
Human UBN1 Is an Ortholog of Yeast Hpc2p and Has an Essential Role in the HIRA/ASF1a Chromatin-Remodeling Pathway in Senescent Cells
Gowrishankar Banumathy et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
IDH1 and IDH2 Mutations in Gliomas
Hai Yan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Dynamics of component exchange at PML nuclear bodies
Stefanie Weidtkamp-Peters et al.
JOURNAL OF CELL SCIENCE (2008)
Arsenic degrades PML or PML - RARα through a SUMO-triggered RNF4/ubiquitin-mediated pathway
Valerie Lallemand-Breitenbach et al.
NATURE CELL BIOLOGY (2008)
Chromatin immunoprecipitation and microarray-based analysis of protein location
Tong Ihn Lee et al.
NATURE PROTOCOLS (2006)
Hyperdynamic plasticity in pluripotent embryonic of chromatin proteins stem cells
E Meshorer et al.
DEVELOPMENTAL CELL (2006)
Merase-independent telomere length maintenance in the absence of alternative lengthening of telomeres-associated promyelocytic leukemia bodies
CL Fasching et al.
CANCER RESEARCH (2005)
Histone H3.1 and H3.3 complexes mediate nucleosome assembly pathways dependent or independent of DNA synthesis
H Tagami et al.
CELL (2004)
The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies
YT Xue et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The histone variant H3.3 marks active chromatin by replication-independent nucleosome assembly
K Ahmad et al.
MOLECULAR CELL (2002)
Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor α degradation
V Lallemand-Breitenbach et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
The tripartite motif family identifies cell compartments
A Reymond et al.
EMBO JOURNAL (2001)
Share Paper
